<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Valsartan from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Valsartan news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 12:49:28 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Valsartan" rel="self" type="application/rss+xml" />

	
<item><title>New Research Report: Malaysia Pharmaceuticals &amp; Healthcare Report Q1 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3989137&amp;HITNO=0&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3989137&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2511975350%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3989137&amp;HITNO=0&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3989137&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2511975350%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Bayer Schering Pharma commences ADVISE in Asia Pacific</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3962165&amp;HITNO=1&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3962165&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2497075023%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3962165&amp;HITNO=1&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3962165&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2497075023%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Bio Spectrum Asia:</description></item>
<item><title>Some Blood Pressure Drugs May Stave Off Dementia</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3955063&amp;HITNO=2&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3955063&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2493654464%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3955063&amp;HITNO=2&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3955063&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2493654464%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medbroadcast:</description></item>
<item><title>Three new Novartis medicines approved in Japan for patients with type 2 diabetes, high blood pressure and adva</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3954385&amp;HITNO=3&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3954385&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2492672119%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3954385&amp;HITNO=3&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3954385&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2492672119%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Bionity.com:</description></item>
<item><title>Left ventricular diastolic function improved by lowering BP</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3951723&amp;HITNO=4&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3951723&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2490367318%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3951723&amp;HITNO=4&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3951723&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2490367318%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MedWire News:</description></item>
<item><title>Novartis Receives Approval For Three New Medicines In Japan</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3945310&amp;HITNO=5&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3945310&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2487039316%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3945310&amp;HITNO=5&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3945310&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2487039316%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>InfoGrok:</description></item>
<item><title>Japan Sanctions Three Novartis Drugs for Hypertension, Advanced Renal Cancer, and Type 2 Diabetes</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937908&amp;HITNO=6&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937908&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483745576%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937908&amp;HITNO=6&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937908&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483745576%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Triple approval for Novartis in Japan</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937042&amp;HITNO=7&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937042&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483316884%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3937042&amp;HITNO=7&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3937042&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2483316884%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmafocus:</description></item>
<item><title>Novartis receives approval for three medicines in Japan</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3935123&amp;HITNO=8&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3935123&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482505929%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3935123&amp;HITNO=8&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3935123&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482505929%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Swiss Novartis gets Japanese approval for three medicines</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934793&amp;HITNO=9&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934793&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482368481%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934793&amp;HITNO=9&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934793&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482368481%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>ADP News:</description></item>
<item><title>Health Canada approves Novartis' Afinitor to treat patients with mRCC</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934243&amp;HITNO=10&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934243&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482123443%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934243&amp;HITNO=10&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934243&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482123443%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Novartis Reveals Approval Of Three Medicines In Japan - Update</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934226&amp;HITNO=11&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934226&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482110778%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934226&amp;HITNO=11&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934226&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482110778%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>RTTNews.com:</description></item>
<item><title>Enzyme Research: Data on enzyme research reported by researchers at Duke University, Division of Endocrinology</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3917840&amp;HITNO=12&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3917840&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2472484810%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3917840&amp;HITNO=12&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3917840&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2472484810%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsRX:</description></item>
<item><title>Hypertension Drugs May Cut Alzheimer's Risk</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3912253&amp;HITNO=13&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3912253&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2470130946%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3912253&amp;HITNO=13&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3912253&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2470130946%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MedicineNet.com:</description></item>
<item><title>Report: Combo hypertension drugs could provide lower doses, be safer</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3911674&amp;HITNO=14&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3911674&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2469791867%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3911674&amp;HITNO=14&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valsartan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3911674&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2469791867%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Cardiovascular Business:</description></item>
</channel></rss>